Philadelphia Risperdal Gynecomastia Lawsuit Attorney
As a young man or boy, who has developed gynecomastia while taking Risperdal, you may seek legal recourse for the harm caused. Risperdal is an antipsychotic drug, whose active ingredient risperidone is manufactured and distributed by Johnson & Johnson. The U.S. Food and Drug Administration (“FDA”) originally approved Risperdal in 1993 for treatment of schizophrenia in adults. Risperdal has recently been approved to treat children with autism, bipolar disorder, and other behavior disorders. The FDA approved the use of Risperdal on children in 2006. The new use of Risperdal on young men and boys is alleged to cause rapid growth of male breast tissue, a condition known as gynecomastia. Within the last decade Risperdal lawsuits allege that the manufacturer and distributor of Risperdal, Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to adequately research the adverse effects of Risperdal on young men and boys, and further failed to adequately warn of the known unfavorable results, specifically breast growth in males. Numerous studies show that these adverse effects can have devastating social and mental impact on young males at a critical time in their developmental growth. If you or a loved one has developed gynecomastia while using Risperdal our Philadelphia surgical errors lawyers may be able to help you obtain compensation for medical bills, lost wages, pain and suffering, and other damages as a result of using Risperdal.
Why Choose Jeff Rosenbaum?
Our litigation team headed by David Rosenbaum has successfully resolved Drug and pharmaceutical claims for over 15 years. We have helped numerous victims of dangerous drugs including people who have taken Phen-Fen (a popular diet drug), Vioxx (a pain reliever) and Paxil (an antidepressant). Most drug claims involve the manufacturer improperly marketing their medication for uses not approved by the FDA or withholding detrimental data from the FDA and the general public. Often thousands of hours of discovery is required to uncover the extent of the marketing scheme and the testing protocols used by the drug company.
Potential side effects include:
- Breast enlargement
- Nipple discharge
- Swollen Nipples
- Breast tenderness
The increased weight gain in males can make early diagnosis of gynecomastia by medical professionals a challenge. Known side effects of Risperdal are significant weight gain and the development of a metabolic disorder, such as type 2 diabetes. In 2006, the Journal of Clinical Psychopharmacology released a report that showed a group of boys who took Risperdal had an increase in the levels of the hormone prolactin, causing breast growth in male children. The overstimulation of the hormone prolactin is the hormone in females that is associated with breast growth and lactation in new mothers. Boys who develop gynecomastia may suffer from breast tenderness, puffy nipples, lactation, unexpected breast discharge, and possible significant breast tissue growth. Gynecomastia complications can often only be reversed through surgical means. These costly procedures may not be covered by one’s health insurance. Typically plastic surgery options include liposuction or a mastectomy, in order to remove excess breast tissue.
Contact Rosenbaum & Associates
If you or a loved one has used Risperdal and suffered from gynecomastia (a condition that causes growth of abnormally large breast in males), you may have the right to legal recourse and compensation for injuries caused such as, mental pain and suffering, reduction surgery expense, hospital bills, and other damages related to the use of Risperdal. If you would like more information please contact the Philadelphia medical malpractice lawyers at Rosenbaum & Associates online or call 1 800 7 LEGAL 7 for a Free Case Evaluation.